Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Endocrinology|August 29, 2022
A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survivalWu-Hu Zhang, He-Li Gao, Wen-Sheng Liu, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 30, 2018
Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinomaHua-Xiang Xu, Shuo Li, Chun-Tao Wu, et al.
The Journal of Clinical Endocrinology and Metabolism|April 15, 2020
Tumor-Infiltrating Neutrophils Predict Poor Survival of Non-Functional Pancreatic Neuroendocrine TumorWu-Hu Zhang, Wen-Quan Wang, He-Li Gao, et al.
Computational and Structural Biotechnology Journal|December 11, 2020
Advances on diagnostic biomarkers of pancreatic ductal adenocarcinoma: A systems biology perspectiveWu-Hu Zhang, Wen-Quan Wang, Xuan Han, et al.
Journal for Immunotherapy of Cancer|October 15, 2020
Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumorsWu-Hu Zhang, Wen-Quan Wang, Xuan Han, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 13, 2018
Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinomaShi-Rong Zhang, Hao Li, Wen-Quan Wang, et al.
Annals of Surgical Oncology|September 2, 2018
Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal AdenocarcinomaShi-Rong Zhang, Lie Yao, Wen-Quan Wang, et al.
Journal of Gastroenterology|March 20, 2021
A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumorsWen-Quan Wang, Wu-Hu Zhang, He-Li Gao, et al.
Pageof 4